We are live on ! Find out more
CLDX icon

Celldex Therapeutics
CLDX

129 hedge funds and large institutions have $949M invested in Celldex Therapeutics in 2013 Q2 according to their latest regulatory filings, with 129 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less call options, than puts

Call options by funds: $7.11M | Put options by funds: $8.22M

Holders
129
Holders Change
+129
Holders Change %
–
% of All Funds
4.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
129
Increased
–
Reduced
–
Closed
–
Calls
$7.11M
Puts
$8.22M
Net Calls
-$1.11M
Net Calls Change
-$1.11M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HFM
126
Hartford Financial Management
Connecticut
$4K +$3.54K +18 New
HNB
127
Huntington National Bank
Ohio
$3K +$2.56K +13 New
JG
128
Jefferies Group
New York
$2K +$1.38K +7 New
PSC
129
Prentiss Smith & Co
Vermont
$2K +$1.38K +7 New
ECM
130
Estabrook Capital Management
New York
$1.69K +$1.38K +7 New
2 3 4 5
6

CLDX Hedge Fund Activity: Q2 2013 in Review

129 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Celldex Therapeutics (CLDX) for Q2 2013, worth a combined $949M.

Buyers outnumbered sellers: 129 funds opened new CLDX positions and 0 closed out — a net gain of 129 holders — while 0 added to existing stakes and 0 trimmed.

  • 129 institutional investors held Celldex Therapeutics (CLDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $949M of Celldex Therapeutics stock for Q2 2013.
  • 129 funds opened new Celldex Therapeutics positions in Q2 2013 and 0 closed out, a net change of +129 holders.

Based on aggregated 13F filings for Q2 2013.